The first digital therapy platform (DTx) with prescription for all oncological diseases.
Mika has raised €10M across 1 funding round from 2 investors, most recently a round in May 2022. Based in Berlin, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2022-05-30 | Other | €10M |
| Debiopharm Group,Ship2B Ventures |
| View deal → |
